Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease
Mesenchymal stem cells (MSCs) represent a heterogeneous population of stromal cells with pluripotent mesenchymal differentiation potential. They have been found to have immunosuppressive properties and the ability to modulate angiogenesis and endogenous tissue repair by in vitro and animal studies....
Saved in:
| Main Authors: | Yi Lin, William J. Hogan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2011/427863 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advancements in graft-versus-host disease prevention in hematopoietic stem cell transplantation
by: Soumyajit Das, et al.
Published: (2025-01-01) -
Mesenchymal Stem Cell Therapy Overcomes Steroid Resistance in Severe Gastrointestinal Acute Graft-Versus-Host Disease
by: Kyoko Moritani, et al.
Published: (2019-01-01) -
Mesenchymal Stem Cell Treatment for Steroid Refractory
Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey
by: Fatih Erbey, et al.
Published: (2016-01-01) -
Enhance the therapeutic efficacy of human umbilical cord-derived mesenchymal stem cells in prevention of acute graft-versus-host disease through CRISPLD2 modulation
by: Qing Xu, et al.
Published: (2025-05-01) -
Role of the regulatory T cells CD4+CD25+ and mesenchymal marrow stem cells in suppressing a graft versus host reaction
by: I. A. Korsunsky, et al.
Published: (2022-11-01)